Consensus U.S. Physical Therapy, Inc.

Equities

USPH

US90337L1089

Market Closed - Nyse Other stock markets 04:00:02 2024-05-31 pm EDT			5-day change	1st Jan Change
102.6 ^USD	+2.21%		+0.73%	+10.12%

May. 21	U.S. Physical Therapy, Inc. Announces Board Changes	CI
May. 16	U S Physical Therapy Insider Sold Shares Worth $268,925, According to a Recent SEC Filing	MT

Evolution of the average Target Price on U.S. Physical Therapy, Inc.

Price target over the last 5 years

History of analyst recommendation changes

44294c2104c387250b7bc09a845e.W7R40BuNqSS4r2fcqqoLIjqqPyCM3wKrOCJ6yfvnwLA.bdA5vGno3hbf5A-fw5M9dmnLSlX5lmTObFE0k7K988ht2By9SsPcSP3CVw~772429a7b23106befe5bffa814485380

Analyst Recommendations on U.S. Physical Therapy, Inc.

U S Physical Therapy Insider Sold Shares Worth $268,925, According to a Recent SEC Filing	May. 16	MT
JPMorgan Adjusts U.S. Physical Therapy's Price Target to $117 From $99, Reiterates Overweight Rating	Mar. 13	MT
Barrington Ups Price Target on U.S. Physical Therapy to $122 From $120 After Strong Q4 Beat, Keeps Outperform Rating	Mar. 01	MT
Barrington Adjusts Price Target on U.S. Physical Therapy to $120 From $111, Maintains Outperform Rating	Jan. 03	MT
JPMorgan Adjusts Price Target on U.S. Physical Therapy to $99 From $108, Maintains Overweight Rating	Nov. 17	MT
Barrington Cuts Price Target on U.S. Physical Therapy to $111 From $124 on 'Tough Stock Market Environment', Reiterates Outperform Rating	Nov. 09	MT
JPMorgan Starts US Physical Therapy at Overweight With $108 Price Target	23-09-22	MT
CJS Securities Upgrades US Physical Therapy to Market Outperform From Market Perform, $120 Price Target	23-09-19	MT
Jefferies Adjusts U.S. Physical Therapy Price Target to $130 From $145, Maintains Buy Rating	23-09-15	MT
Barrington Boosts Price Target on U.S. Physical Therapy to $124 From $116, Keeps Outperform Rating	23-08-14	MT
BofA Securities Initiates U.S. Physical Therapy With Buy Rating, $138 Price Target	23-06-30	MT
Barrington Research Adjusts Price Target on U.S. Physical Therapy to $110 From $107, Maintains Outperform Rating	23-02-24	MT
Barrington Research Lowers U.S. Physical Therapy's Price Target to $107 From $123, Maintains Outperform Rating	22-08-05	MT
Barrington Research Trims US Physical Therapy's Price Target to $123 From $144, Maintains Outperform Rating	22-02-25	MT
Barrington Adjusts Price Target on US Physical Therapy to $144 From $142, Maintains Outperform Rating	22-01-03	MT
CJS Securities Upgrades U.S. Physical Therapy to Outperform From Market Perform, Lower Price Target to $120 From $126	21-12-14	MT
Barrington Adjusts Price Target on US Physical Therapy to $142 From $139 on Long-Term Confidence, Maintains Outperform Rating	21-12-10	MT
Sidoti Upgrades U.S. Physical Therapy to Buy From Neutral, Keeps $124 Price Target	21-11-22	MT
U S PHYSICAL THERAPY : Barrington Adjusts Price Target on U.S. Physical Therapy to $139 From $130 After 'Exceptionally Strong Q2', Maintains Outperform Rating	21-08-06	MT
U S PHYSICAL THERAPY : Barrington Research Upgrades U.S. Physical Therapy to Outperform From Market Perform, $130 Price Target	21-05-07	MT
U S PHYSICAL THERAPY : Barrington Research Downgrades US Physical Therapy to Market Perform From Outperform; Removes $116 Price Target	21-02-26	MT
U S PHYSICAL THERAPY : Barrington Research Adjusts Price Target on US Physical Therapy to $116 From $100, Keeps Outperform Rating	20-11-06	MT